PAPER Lee J, Herman JP, Mattson MP
SEARCH RESULTS
331941 RESULTS
PAPER Klegeris A, McGeer PL
R-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
Exp Neurol. 2000 Dec;166(2):458-64. PubMed.PAPER Bennecib M, Gong CX, Grundke-Iqbal I, Iqbal K
Role of protein phosphatase-2A and-1 in the regulation of GSK-3, cdk5 and cdc2 and the phosphorylation of tau in rat forebrain.
FEBS Lett. 2000 Nov 17;485(1):87-93. PubMed.PAPER Karlsson E, Jolkkonen M, Mulugeta E, Onali P, Adem A
Snake toxins with high selectivity for subtypes of muscarinic acetylcholine receptors.
Biochimie. 2000 Sep-Oct;82(9-10):793-806. PubMed.PAPER Chang P, Su Y
Protocol for quantitative and qualitative analyses of the in vitro aggregation of synthetic beta-amyloid. A method applicable to the identification of substances that may have therapeutic efficacy for Alzheimer's disease.
Brain Res Brain Res Protoc. 2000 Nov;6(1-2):6-12. PubMed.PAPER Gamblin TC, King ME, Kuret J, Berry RW, Binder LI
Oxidative regulation of fatty acid-induced tau polymerization.
Biochemistry. 2000 Nov 21;39(46):14203-10. PubMed.PAPER Primot A, Baratte B, Gompel M, Borgne A, Liabeuf S, Romette JL, Jho EH, Costantini F, Meijer L
Purification of GSK-3 by affinity chromatography on immobilized axin.
Protein Expr Purif. 2000 Dec;20(3):394-404. PubMed.PAPER Teri L, Logsdon RG, Peskind E, Raskind M, Weiner MF, Tractenberg RE, Foster NL, Schneider LS, Sano M, Whitehouse P, Tariot P, Mellow AM, Auchus AP, Grundman M, Thomas RG, Schafer K, Thal LJ,
Treatment of agitation in AD: a randomized, placebo-controlled clinical trial.
Neurology. 2000 Nov 14;55(9):1271-8. PubMed.PAPER Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J
The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease.
Neurology. 2000 Nov 14;55(9):1278-83. PubMed.PAPER Reynolds WF, Hiltunen M, Pirskanen M, Mannermaa A, Helisalmi S, Lehtovirta M, Alafuzoff I, Soininen H
MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males.
Neurology. 2000 Nov 14;55(9):1284-90. PubMed.PAPER Stern Y, Moeller JR, Anderson KE, Luber B, Zubin NR, DiMauro AA, Park A, Campbell CE, Marder K, Bell K, Van Heertum R, Sackeim HA
Different brain networks mediate task performance in normal aging and AD: defining compensation.
Neurology. 2000 Nov 14;55(9):1291-7. PubMed.PAPER Kheterpal I, Zhou S, Cook KD, Wetzel R
Abeta amyloid fibrils possess a core structure highly resistant to hydrogen exchange.
Proc Natl Acad Sci U S A. 2000 Dec 5;97(25):13597-601. PubMed.PAPER da Silva AM, PayĆ£o SL, Borsatto B, Bertolucci PH, Smith MA
Quantitative evaluation of the rRNA in Alzheimer's disease.
Mech Ageing Dev. 2000 Dec 1;120(1-3):57-64. PubMed.PAPER Barbanti P, Fabbrini G, Ricci A, Bruno G, Cerbo R, Bronzetti E, Amenta F, Luigi Lenzi G
Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease.
Mech Ageing Dev. 2000 Dec 1;120(1-3):65-75. PubMed.PAPER Petrie EC, Peskind ER, Dobie DJ, Veith RC, Raskind MA